Johann Brandes, MD
Fall 2020-Spring 2022
Keeping patients free from complications and out of the hospital has always been a sign of good and proactive medicine, but in times of COVID and strained budgets this takes on an ever greater importance both in terms of patient safety and stewardship of resources. As an oncologist at TN Oncology my patients are often particularly vulnerable and I believe that integration and analysis of the wealth of data generated on a daily basis will allow me to develop clinical decision support systems to identify those at highest risk for complications, tailor treatments based on clinical and genetic/genomic characteristics and potentially de-escalate treatment intensity where appropriate.
Prior to coming to TN Oncology, I completed residency and fellowship training in Oncology and Pulmonary and Critical Care Medicine at Johns Hopkins and held faculty appointments at Johns Hopkins and Emory University. My research focused on the identification of epigenetic mechanisms in lung carcinogenesis and resistance to treatment and I used large scale analysis of data form the Department of Veterans affairs to validate hypotheses generated in the laboratory. Specifically, we studied cancer risk after exposure to several potentially preventative treatment interventions.
Personally, I enjoy running, mountain biking and music. Recently, my eleven year old son has started challenging me in complicated strategy games.